Latest Velan Capital Investment Management LP Stock Portfolio
Velan Capital Investment Management LP Performance:
2024 Q4: 9.27%YTD: 27.43%2023: 5.4%
Performance for 2024 Q4 is 9.27%, and YTD is 27.43%, and 2023 is 5.4%.
About Velan Capital Investment Management LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Velan Capital Investment Management LP reported an equity portfolio of $115.9 Millions as of 31 Dec, 2024.
The top stock holdings of Velan Capital Investment Management LP are JSPR, PRAX, HRTX. The fund has invested 26.4% of it's portfolio in JASPER THERAPEUTICS INC and 19.9% of portfolio in PRAXIS PRECISION MEDICINES I.
The fund managers got completely rid off SCPHARMACEUTICALS INC (SCPH), TELA BIO INC (TELA) and OPTINOSE INC (OPTN) stocks. They significantly reduced their stock positions in CONTEXT THERAPEUTICS INC (CNTX) and PRAXIS PRECISION MEDICINES I (PRAX). Velan Capital Investment Management LP opened new stock positions in SPRINGWORKS THERAPEUTICS INC (SWTX), VERONA PHARMA PLC (VRNA) and REPLIMUNE GROUP INC (REPL). The fund showed a lot of confidence in some stocks as they added substantially to PROTARA THERAPEUTICS INC (TARA), ZEVRA THERAPEUTICS INC and CORBUS PHARMACEUTICALS HLDGS (CRBP).
The top stock holdings of Velan Capital Investment Management LP are JSPR, PRAX, HRTX. The fund has invested 26.4% of it's portfolio in JASPER THERAPEUTICS INC and 19.9% of portfolio in PRAXIS PRECISION MEDICINES I.
The fund managers got completely rid off SCPHARMACEUTICALS INC (SCPH), TELA BIO INC (TELA) and OPTINOSE INC (OPTN) stocks. They significantly reduced their stock positions in CONTEXT THERAPEUTICS INC (CNTX) and PRAXIS PRECISION MEDICINES I (PRAX). Velan Capital Investment Management LP opened new stock positions in SPRINGWORKS THERAPEUTICS INC (SWTX), VERONA PHARMA PLC (VRNA) and REPLIMUNE GROUP INC (REPL). The fund showed a lot of confidence in some stocks as they added substantially to PROTARA THERAPEUTICS INC (TARA), ZEVRA THERAPEUTICS INC and CORBUS PHARMACEUTICALS HLDGS (CRBP).
Velan Capital Investment Management LP Annual Return Estimates Vs S&P 500
Our best estimate is that Velan Capital Investment Management LP made a return of 9.27% in the last quarter. In trailing 12 months, it's portfolio return was 27.43%.
New Buys
| Ticker | $ Bought |
|---|---|
| springworks therapeutics inc | 6,702,840 |
| verona pharma plc | 2,322,000 |
| replimune group inc | 2,196,350 |
| nurix therapeutics inc | 1,844,230 |
| perspective therapeutics inc | 1,595,000 |
| eledon pharmaceuticals inc | 1,334,770 |
| kura oncology inc | 1,306,500 |
| collegium pharmaceutical inc | 821,825 |
New stocks bought by Velan Capital Investment Management LP
Additions
| Ticker | % Inc. |
|---|---|
| protara therapeutics inc | 175 |
| zevra therapeutics inc | 50.00 |
| tourmaline bio inc | 27.96 |
| corbus pharmaceuticals hldgs | 13.4 |
Additions to existing portfolio by Velan Capital Investment Management LP
Reductions
| Ticker | % Reduced |
|---|---|
| context therapeutics inc | -93.03 |
| praxis precision medicines i | -14.45 |
Velan Capital Investment Management LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| tela bio inc | -1,890,950 |
| scpharmaceuticals inc | -2,360,570 |
| skye bioscience inc | -825,288 |
| optinose inc | -1,438,230 |
| optinose inc | -1,438,230 |
Velan Capital Investment Management LP got rid off the above stocks
Sector Distribution
Velan Capital Investment Management LP has about 89% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 89 |
| Others | 11 |
Market Cap. Distribution
Velan Capital Investment Management LP has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 38.5 |
| MICRO-CAP | 33.7 |
| UNALLOCATED | 11 |
| NANO-CAP | 8.8 |
| MID-CAP | 7.9 |
Stocks belong to which Index?
About 24.3% of the stocks held by Velan Capital Investment Management LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 75.7 |
| RUSSELL 2000 | 24.3 |
Velan Capital Investment Management LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Velan Capital Investment Management LP
Velan Capital Investment Management LP has 45 stocks in it's portfolio. About 86.6% of the portfolio is in top 10 stocks. HRTX proved to be the most loss making stock for the portfolio. PRAX was the most profitable stock for Velan Capital Investment Management LP last quarter.
Last Reported on: 14 Feb, 2025| Ticker | Namesorted descending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| JSPR | jasper therapeutics inc | 26.45 | 1,433,830 | 30,655,200 | unchanged | 0.00 | ||
Historical Trend of JASPER THERAPEUTICS INC Position Held By Velan Capital Investment Management LPWhat % of Portfolio is JSPR?:Number of JSPR shares held:Change in No. of Shares Held: | ||||||||
| PRAX | praxis precision medicines i | 19.92 | 300,000 | 23,088,000 | reduced | -14.45 | ||
| HRTX | heron therapeutics inc | 9.22 | 6,986,740 | 10,689,700 | unchanged | 0.00 | ||
| tourmaline bio inc | 7.42 | 423,795 | 8,594,560 | added | 27.96 | |||
| TARA | protara therapeutics inc | 7.20 | 1,579,000 | 8,337,120 | added | 175 | ||
| SWTX | springworks therapeutics inc | 5.78 | 185,520 | 6,702,840 | new | |||
| RZLT | rezolute inc | 3.38 | 800,000 | 3,920,000 | unchanged | 0.00 | ||
| LQDA | liquidia corporation | 3.04 | 300,000 | 3,528,000 | unchanged | 0.00 | ||
| zevra therapeutics inc | 2.16 | 300,000 | 2,502,000 | added | 50.00 | |||
| NSPR | inspiremd inc | 2.05 | 904,029 | 2,377,600 | unchanged | 0.00 | ||
| VRNA | verona pharma plc | 2.00 | 50,000 | 2,322,000 | new | |||
| REPL | replimune group inc | 1.90 | 181,367 | 2,196,350 | new | |||
| NRIX | nurix therapeutics inc | 1.59 | 97,889 | 1,844,230 | new | |||
| perspective therapeutics inc | 1.38 | 500,000 | 1,595,000 | new | ||||
| ELDN | eledon pharmaceuticals inc | 1.15 | 323,973 | 1,334,770 | new | |||
| KURA | kura oncology inc | 1.13 | 150,000 | 1,306,500 | new | |||
| COLL | collegium pharmaceutical inc | 0.71 | 28,685 | 821,825 | new | |||
| AVTX | avalo therapeutics inc | 0.70 | 109,972 | 817,092 | new | |||
| CRBP | corbus pharmaceuticals hldgs | 0.58 | 56,700 | 669,060 | added | 13.4 | ||
| TENX | tenax therapeutics inc | 0.44 | 83,333 | 515,831 | unchanged | 0.00 | ||
